cupure logo
Moderna and Merck report positive trial results for experimental melanoma vaccine
VRT NWS
Health·

Moderna and Merck report positive trial results for experimental melanoma vaccine

Moderna and Merck announced encouraging preliminary results from a trial of their experimental vaccine for melanoma, a type of skin cancer. The vaccine, combined with Merck's Keytruda, aims to reduce cancer recurrence and metastasis.

Comments

Read this story in other languages

Covered by the press in 8 countries

Among the outlets we follow

  • France8
  • United States7
  • Italy6
  • Spain4
  • Belgium2
  • Germany1
  • Qatar1
  • United Kingdom1

Similar News from External Sources

How we write our stories →

Cupure writes the day's most important stories in seven languages. The name comes from the French 'coupure de journal' — a newspaper clipping — our promise of concise, relevant news.

For advertising inquiries, content suggestions, or to flag a concern about a news item or content, you can reach us. We value your feedback. Contact form